BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11976346)

  • 1. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
    Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
    J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
    Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
    J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.
    Lellek H; Kirsten R; Diehl I; Apostel F; Buck F; Greeve J
    J Biol Chem; 2000 Jun; 275(26):19848-56. PubMed ID: 10781591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.
    Lehmann DM; Galloway CA; Sowden MP; Smith HC
    Nucleic Acids Res; 2006; 34(11):3299-308. PubMed ID: 16820530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
    J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop.
    Richardson N; Navaratnam N; Scott J
    J Biol Chem; 1998 Nov; 273(48):31707-17. PubMed ID: 9822632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
    Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.
    Dance GS; Sowden MP; Yang Y; Smith HC
    Nucleic Acids Res; 2000 Jan; 28(2):424-9. PubMed ID: 10606639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.